Three-dimensional Bone Regeneration Using Custom-made Meshes With and Without Collagen Membrane
1 other identifier
interventional
30
1 country
1
Brief Summary
The presence of alveolar ridge deficiencies is considered major limitation to achieve an implant-prosthetic restoration with high aesthetics and stability over time. Guided Bone Regeneration (GBR) can be considered an effective solution for bone augmentation. The most advanced technology of GBR is the customized titanium mesh, which is developed with a fully digital work flow system. The aim of this study is to evaluate complications and bone augmentation rates after GBR, based on customized meshes with or without collagen membranes. After ethical committee approval, 30 patients with horizontal and/or vertical bone defects were enrolled and treated according to the study protocol. During reconstructive surgery (T0), patients were randomly divided into two study groups: 15 patients were treated by means of a custom-made mesh without collagen membrane (Group A - Control Group), while 15 patients were treated by means of a custom-made titanium mesh with a collagen membrane (Group B - Test Group). All sites were grafted with a mixture 50:50 of autogenous bone and xenograft and primary closures of surgical sites were obtained to ensure a submerged healing of the meshes. After 6 months (T1), re-entry surgery was completed to remove the meshes, evaluate the augmented volume and to place implants in the augmented sites. After 3 months (T2), soft tissue management was accomplished with implant exposure and a connective tissue graft, before prosthetic restoration (T3). Data collection included surgical and healing complications, planned bone volume (PBV) and reconstructed bone volume (RBV), pseudo-periosteum type, bone density, implant success, and crestal bone loss. A statistical analysis of recorded data was performed to investigate any statistically significant differences between the study group and statistical significance was set at a=0.05.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2017
CompletedFirst Submitted
Initial submission to the registry
February 12, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedFirst Posted
Study publicly available on registry
February 27, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2022
CompletedAugust 3, 2022
August 1, 2022
2 years
February 12, 2019
August 2, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
The rate of healing complications after reconstructive surgery
Healing complications are evaluated based on the chronological order in which they occur: * immediate exposure occurs within the 1st month * early exposure occurs between the 1st and the 3rd month * late exposure occurs after the 3rd month Evaluation of low-grade and high-grade infection of medical devices used for bone regeneration. The former complications are classified as: * Class A, including flap damage (soft tissue perforation or laceration) * Class B, including neurological damage (paresthesia or disesthesia) * Class C,including vascular damage (hemorrhage). The latter complications are divided into four classes, according to the presence and extent of exposure, as well as the presence of a purulent exudate: * Class I, membrane exposure \<3 mm, no purulent exudate * Class II membrane exposure \>=3mm, no purulent exudate * Class III: membrane exposure, with purulent exudate
6 months
Secondary Outcomes (16)
Level of anxiety of the patient measured with a Visual Analogue Scale (VAS)
Immediately before/after surgery
Pain level of the patient measured on a Visual Analogue Scale (VAS)
Post operative from immediately after surgery to the 14th day after the surgery
Total Number of painkillers taken post-operative
Post operative from immediately after surgery to the 14th day after the surgery
Dosage of painkillers
Post operative from immediately after surgery to the 14th day after the surgery
Limitation in daily functions measured on a Visual Analogue Scale (VAS)
Post operative from immediately after surgery to the 14th day after the surgery
- +11 more secondary outcomes
Study Arms (2)
Group A - control Group
ACTIVE COMPARATORCustomized titanium mesh without collagen membrane 15 patients will undergo bone regeneration with custom-made mesh without a collagen membrane. (Meshes - 3D-mesh BTK, Biotec, Vicenza, Italy.) Digitally designed by an operator before the surgery (digital technique).
Group B - Test Group
EXPERIMENTALCustomized titanium mesh with collagen membrane 15 patients will undergo bone regeneration with a custom-made titanium mesh (BTK, Biotec- Vicenza, Italy). Digitally designed by an operator before the surgery (digital technique), covered by collagen membrane (Cytoplast RTM, Osteogenics, deore materials, Verona, Italy).
Interventions
Titanium meshes cad cam laser-sintered were applied in sites with alveolar bone deficiency in order to regenerate the bone volume in need of implant-prosthetic restorations.
Eligibility Criteria
You may not qualify if:
- Poor oral hygiene,
- Untreated periodontal disease
- Smoking habit\> 10 cigarettes / day;
- Abuse of alcohol or drugs
- Pregnancy
- Patients with odontostomatological infections and / or systemic infections in progress;
- Patient with uncontrolled diabetes mellitus or other metabolic diseases;
- Patients with severe changes in liver and kidney function.
- Patients with confirmed uncontrolled autoimmune disorders.
- Patients subjected radiation therapy in the head or neck region in the last 5 years.
- Patients undergoing immunosuppressive and / or immunocompromised therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- GBR Academylead
Study Sites (1)
School of Dentistry - University of Bologna
Bologna, 40126, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Giuseppe Corinaldesi, MD, DDS, MS
school of dentistry - University of Bologna
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Surgeon is masked until the envelope opening at the end of the surgery, just before surgery.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- NETWORK
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 12, 2019
First Posted
February 27, 2020
Study Start
December 1, 2017
Primary Completion
December 1, 2019
Study Completion
August 1, 2022
Last Updated
August 3, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- From May 2020
- Access Criteria
- Access credentials to journal resources
Original articles in international journals